Jack A. Khattar
Known title: President, CEOCIK: 0001539937
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cognition Therapeutics Sets FDA Type C Meeting for Oct. 20. Cognition Therapeutics announced it will hold a Type C meeting with the FDA on October 20 regarding the planned trial of zervimesine. This regulatory step is a key milestone for the drug's development path. The company's stock currently trades within a wide 52-week range, reflecting the uncertainty typical of clinical-stage biotech firms.
Transaction History
| SUPN | ▲ Buy | Option Exercise | 29,849 | $0 | 8/12/2026 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 12,642 | $589K | 8/12/2026 | View on chart |
| CGTX | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 | View on chart |
| SUPN | ▼ Sell | Other | 12,500 | — | 3/13/2026 | View on chart |
| SUPN | ▼ Sell | Other | 12,500 | — | 3/13/2026 | View on chart |
| SUPN | ▼ Sell | Open Market | 24,138 | $1.2M | 3/13/2026 | View on chart |
| SUPN | ▼ Sell | Open Market | 10,742 | $548K | 3/13/2026 | View on chart |
| SUPN | ▼ Sell | Open Market | 120 | $6K | 3/13/2026 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 38,640 | $0 | 3/6/2026 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 16,574 | $907K | 3/6/2026 | View on chart |
| SUPN | ▼ Sell | Open Market | 58,371 | $3.0M | 10/9/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 1,529 | $79K | 10/9/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 81,250 | $2.1M | 10/9/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 20,000 | $0 | 10/2/2025 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 7,796 | $360K | 10/2/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 19,320 | $0 | 10/2/2025 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 7,529 | $348K | 10/2/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 2,267 | $57K | 10/2/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 1,904 | $92K | 10/2/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 53,785 | $1.4M | 10/1/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 40,173 | $1.9M | 10/1/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 11,510 | $291K | 9/30/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 8,588 | $414K | 9/30/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 13,688 | $346K | 9/29/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 10,235 | $491K | 9/29/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 47,940 | $622K | 9/23/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 29,513 | $1.4M | 9/23/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 27,060 | $351K | 9/22/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 16,587 | $780K | 9/22/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 8,074 | $204K | 9/8/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 6,322 | $293K | 9/8/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 73,176 | $1.9M | 9/5/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 55,578 | $2.6M | 9/5/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 38,779 | $503K | 8/28/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 24,150 | $1.1M | 8/28/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 10,650 | $480K | 8/27/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 17,195 | $223K | 8/27/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 1,000 | $45K | 8/25/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 1,611 | $21K | 8/25/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 1,500 | $68K | 8/22/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 2,415 | $31K | 8/22/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 60,000 | $779K | 8/6/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 38,500 | $1.5M | 8/6/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 60,000 | $779K | 8/6/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 38,000 | $1.6M | 8/6/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 81,250 | $2.1M | 8/6/2025 | View on chart |
| SUPN | ▼ Sell | Open Market | 63,500 | $2.7M | 8/6/2025 | View on chart |
| CGTX | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 | View on chart |
| SUPN | ▼ Sell | Other | 16,850 | — | 4/2/2025 | View on chart |
| SUPN | ▼ Sell | Other | 16,850 | — | 4/2/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 35,000 | $0 | 3/10/2025 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 16,805 | $539K | 3/10/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 38,640 | $0 | 3/7/2025 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 18,581 | $727K | 3/7/2025 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 38,640 | $0 | 12/27/2024 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 18,567 | $661K | 12/27/2024 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 14,000 | $0 | 12/27/2024 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 6,666 | $237K | 12/27/2024 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 125,000 | $1.1M | 11/8/2024 | View on chart |
| SUPN | ▼ Sell | Open Market | 125,000 | $4.5M | 11/8/2024 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 125,000 | $1.1M | 11/7/2024 | View on chart |
| SUPN | ▼ Sell | Open Market | 125,000 | $4.6M | 11/7/2024 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 10,045 | $351K | 9/3/2024 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 21,000 | $0 | 9/3/2024 | View on chart |
| CGTX | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 35,000 | $0 | 2/28/2024 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 16,788 | $469K | 2/28/2024 | View on chart |
| SUPN | ▼ Sell | Other | 16,500 | — | 2/12/2024 | View on chart |
| SUPN | ▼ Sell | Other | 16,500 | — | 2/12/2024 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 11,958 | $331K | 12/22/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 25,000 | $0 | 12/22/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 35,000 | $0 | 9/7/2023 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 16,804 | $539K | 9/7/2023 | View on chart |
| CGTX | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 | View on chart |
| SUPN | ▼ Sell | Tax Withholding | 15,005 | $547K | 5/11/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 31,250 | $0 | 5/11/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 20,000 | $0 | 3/14/2023 | View on chart |
| SUPN | ▼ Sell | Other | 8,750 | — | 2/15/2023 | View on chart |
| SUPN | ▼ Sell | Other | 8,750 | — | 2/15/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 330 | $3K | 2/3/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 200 | $8K | 2/3/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 22,515 | $215K | 2/2/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 13,532 | $569K | 2/2/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 498 | $5K | 2/1/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 300 | $13K | 2/1/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 1,620 | $15K | 1/31/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 976 | $41K | 1/31/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 8,080 | $77K | 1/18/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 4,936 | $199K | 1/18/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 41,920 | $401K | 1/17/2023 | View on chart |
| SUPN | ▼ Sell | Open Market | 25,446 | $1.0M | 1/17/2023 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 18,472 | $177K | 12/21/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 11,354 | $433K | 12/21/2022 | View on chart |
| SUPN | ▲ Buy | Grant | 15,625 | $0 | 12/21/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 6,528 | $62K | 12/20/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 4,006 | $152K | 12/20/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 17,794 | $170K | 11/25/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 11,135 | $392K | 11/25/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 2,259 | $79K | 11/23/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 3,616 | $35K | 11/23/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 959 | $9K | 11/22/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 600 | $21K | 11/22/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 848 | $8K | 11/21/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 531 | $19K | 11/21/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 1,115 | $39K | 11/15/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 1,783 | $17K | 11/15/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 1,380 | $47K | 9/14/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 5,895 | $0 | 9/14/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 9,182 | $312K | 8/16/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 39,530 | $0 | 8/16/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 14,690 | $500K | 8/16/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 10,813 | $368K | 8/15/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 46,575 | $0 | 8/15/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 17,302 | $589K | 8/15/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 44,900 | $0 | 8/10/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 28,437 | $888K | 8/10/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 63,100 | $0 | 8/9/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 39,431 | $1.2M | 8/9/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 10,032 | $322K | 8/8/2022 | View on chart |
| SUPN | ▼ Sell | Open Market | 107,875 | $3.4M | 8/8/2022 | View on chart |
| SUPN | ▲ Buy | Option Exercise | 192,000 | $0 | 8/8/2022 | View on chart |
| SUPN | ▼ Sell | Other | 10,750 | — | 3/18/2022 | View on chart |
| SUPN | ▼ Sell | Other | 10,750 | — | 3/18/2022 | View on chart |
| SUPN | ▲ Buy | Grant | 60,000 | $0 | 3/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Supernus mentioned in healthcare stock screening article
Supernus Pharmaceuticals was included in a recent Yahoo Finance article discussing healthcare stocks. The piece highlights specific names for investor attention while noting others to avoid, providing context for the company's current market visibility. This media coverage adds to the narrative surrounding the stock without introducing new fundamental data.
Supernus mentioned in healthcare stock screening article. Supernus Pharmaceuticals was included in a recent Yahoo Finance article discussing healthcare stocks. The piece highlights specific names for investor attention while noting others to avoid, providing context for the company's current market visibility. This media coverage adds to the narrative surrounding the stock without introducing new fundamental data.